Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Ticker Scorecard - HALO

Basics
Company: Halozyme Therapeutics, Inc.
IPO Date: March 16, 2004
Sector: Healthcare
Industry: Biotech
Market Cap: $7.42B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.36 | 2.17%
Avg Daily Range (30 D): $0.62 | 1.16%
Avg Daily Range (90 D): $0.81 | 1.55%
Institutional Daily Volume
Avg Daily Volume: .93M
Avg Daily Volume (30 D): 1M
Avg Daily Volume (90 D): 1.24M
Trade Size
Avg Trade Size (Sh.): 112
Avg Trade Size (Sh.) (30 D): 56
Avg Trade Size (Sh.) (90 D): 61
Institutional Trades
Total Inst.Trades: 8,193
Avg Inst. Trade: $2.55M
Avg Inst. Trade (30 D): $2.96M
Avg Inst. Trade (90 D): $3.04M
Avg Inst. Trade Volume: .08M
Avg Inst. Trades (Per Day): 3
Market Closing Trades
Avg Closing Trade: $4.65M
Avg Closing Trade (30 D): $9.48M
Avg Closing Trade (90 D): $11.3M
Avg Closing Volume: 147.73K
   
News
Nov 11, 2024 @ 4:59 PM
Needle Free Injectors Market Is Expected To Reach ...
Source: Dimension Market Research
Jun 27, 2024 @ 1:50 PM
Why This 1 Momentum Stock Could Be a Great Additio...
Source: Zacks Equity Research
Jun 20, 2024 @ 1:45 PM
Are You a Growth Investor? This 1 Stock Could Be t...
Source: Zacks Equity Research
Jun 17, 2024 @ 1:40 PM
Here's Why Halozyme Therapeutics (HALO) is a Stron...
Source: Zacks Equity Research
Jun 14, 2024 @ 3:30 PM
Why Is Kodiak Sciences (KOD) Down 26.2% Since Last...
Source: Zacks Equity Research
Financials
  TTM Q3 2024 Q2 2024
Basic EPS $3.07 $1.08 $.73
Diluted EPS $3.02 $1.05 $.72
Revenue $ 947.36M $ 290.08M $ 231.35M
Gross Profit $ 777.7M $ 240.66M $ 191.75M
Net Income / Loss $ 392.47M $ 137.01M $ 93.25M
Operating Income / Loss $ 477.01M $ 163.2M $ 117.24M
Cost of Revenue $ 169.66M $ 49.43M $ 39.61M
Net Cash Flow $ -119.91M $ -33.55M $ 23.24M
PE Ratio 19.45